-
公开(公告)号:BR112016006344A2
公开(公告)日:2018-01-09
申请号:BR112016006344
申请日:2014-09-11
Applicant: LEIDOS INC , STC UNM
Inventor: AMY RENE NOE , BRYCE CHACKERIAN , DAVID PEABODY , GABRIEL M GUTIERREZ , JAMES PANNUCCI , SCOTT BUDD WINRAM , STEVE CHIENWEN HUANG
Abstract: resumo vacina contra a malária, composição e métodos, as modalidades da presente invenção referem-se a vacinas contra a malária contendo uma partícula semelhante a vírus (vlp) de um bacteriófago exibindo um peptídeo heterólogo identificado por meio de seleção por afinidade, como um mimotopo antimalárico. 1/1
-
公开(公告)号:BR112014017242A8
公开(公告)日:2017-07-04
申请号:BR112014017242
申请日:2013-01-10
Applicant: STC UNM
Inventor: BRYCE CHACKERIAN , DAVID PEABODY , EBENEZER TUMBAN
Abstract: resumo patente de invenção: "vlps contendo hpv l2 imunogênico e composições e métodos relacionados". em um aspecto, a presente invenção refere-se às partículas semelhantes a vírus contendo hpv l2 imunogênicas (vlps). as composições relacionadas (por exemplo, vacinas), constructos de ácido nucleico, e os métodos terapêuticos são também fornecidos. em certos aspectos, as vlp são compostas por meio de um polipeptídeo de revestimento dos bacteriófagos pp7 ou ms2, em que a proteína de revestimento é modificada por meio da inserção de antígenos de peptídeos derivados de hpv l2, e em que o peptídeo hpv l2 é apresentado na vlp e pp7 ou encapsida ms2 mrna. especificamente, as vlps da presente invenção exibem os peptídeos l2 na região n-terminal da proteína de revestimento do bacteriófago. surpreendentemente, estas vlps exibindo l2 induzem mais amplamente as respostas de anticorpos neutralizantes do que quando o mesmo peptídeo é apresentado no loop ab de modo que a resposta imunogênica é aumentada por meio de um fator de pelo menos 10. vlps imunogênicas e composições relacionadas da presente invenção induzem a altas respostas de anticorpos de título contra hpv l2 e protegem contra o desafio com hpv in vivo.
-
公开(公告)号:CA2708743C
公开(公告)日:2016-08-30
申请号:CA2708743
申请日:2008-12-10
Applicant: STC UNM
Inventor: CHEN JINGKUANG
IPC: A61B8/00
Abstract: A photoacoustic medical imaging device may include a substrate, an array of ultrasonic transducers on the substrate, at least one groove etched on the substrate, at least one optical fiber, and at least one facet. Each optical fiber is disposed in one of the grooves. Each facet is etched in one of the grooves and coated with a layer of metal having high infrared reflectivity. Each optical fiber is configured to guide infrared light from a light source through the fiber and toward the respective facet. The facet is configured to reflect the infrared light toward a target.
-
公开(公告)号:HK1208399A1
公开(公告)日:2016-03-04
申请号:HK15109172
申请日:2015-09-18
Applicant: STC UNM
Inventor: SEROV ALEXEY , ATANASSOV PLAMEN B , HALEVI BARR , SHORT PAUL
IPC: B01J20060101
-
公开(公告)号:MX2014004415A
公开(公告)日:2015-06-05
申请号:MX2014004415
申请日:2012-10-12
Applicant: STC UNM
Inventor: ASHLEY CARLEE ERIN , BRINKER C JEFFREY , CARNES ERIC C , FEKRAZAD MOHAMMAD HOUMAN , FELTON LINDA A , NEGRETE OSCAR , PADILLA DAVID PATRICK , WILKINSON BRIAN S , WILKINSON DAN C , WILLMAN CHERYL L
IPC: A61K9/16 , A61K31/7088 , A61K31/7105 , A61K38/17 , A61K47/48 , A61K48/00 , A61K49/08
Abstract: La presente invención se refiere a protocélulas específicamente dirigidas a la células de cáncer hepatocelular y a otras células cancerosas, las cuales comprenden un núcleo de sílice nanoporoso que soporta una bicapa lipídica; al menos un agente que facilita la muerte de la célula cancerosa (como la tradicional molécula pequeña), una carga macromolecular (por ejemplo, ARNsi o una toxina proteica como la cadena A de la toxina ricina o la cadena A de la toxina diftérica) y/o un ADN plasmídico empaquetado con histona dispuesto dentro del núcleo de sílice nanoporoso (de preferencia, superenrollado para empaquetar con más eficiencia el ADN en las protocélulas), que opcionalmente puede modificarse con una secuencia de localización nuclear que ayude a localizar las protocélulas dentro del núcleo de la célula cancerosa y con la capacidad de expresar péptidos que participan en el tratamiento (apoptosis/muerte celular) de la célula cancerosa o como un reportero, un péptido dirigido cuyo objetivo son las células cancerosas en el tejido que se va a tratar, de manera que la unión de las protocélulas con las células objetivo sea específica y mejorada; y un péptido fusogénico que promueve el escape endosómico de las protocélulas y el ADN encapsulado. Las protocélulas según la presente invención se pueden usar para tratar el cáncer, en especial el cáncer hepatocelular (de hígado), utilizando novedosos péptidos de unión (péptidos c-MET) que se unen de manera selectiva al tejido hepatocelular, o para funcionar en el diagnóstico de cáncer, incluido el tratamiento oncológico o también en el desarrollo de medicamentos.
-
公开(公告)号:CA2926934A1
公开(公告)日:2015-04-16
申请号:CA2926934
申请日:2014-09-24
Applicant: STC UNM
Inventor: EDWARDS JEREMY SCOTT
IPC: C12Q1/68
Abstract: The disclosure describes a method for sequencing long portions of DNA sequence by assembling a plurality of shorter polynucleotide reads. Generally, The method includes annealing a plurality of primers to a denatured DNA molecule, appending a barcode polynucleotide to the 5' end of the primer, subjecting the DNA molecules to a plurality of cycles of (1) pooling, (2) dividing, and (3) appending a barcode polynucleotide to the 5' end of the primer, sequencing the barcode polynucleotides and the genomic DNA, and assembling the short read polynucleotide sequences having identical barcode polynucleotides.
-
公开(公告)号:CA2920250A1
公开(公告)日:2015-02-05
申请号:CA2920250
申请日:2014-08-01
Applicant: STC UNM , EDWARDS JEREMY SCOTT
Inventor: EDWARDS JEREMY SCOTT
IPC: C12Q1/68
Abstract: This disclosure describes, in one aspect, methods for DNA sequencing and performing epigenomic analyses. Generally, the methods include immobilizing a plurality of copies of a DNA molecule on a surface, stretching at least a portion of the immobilized DNA molecules, and sequencing at least a portion of the immobilized, stretched DNA molecules.
-
公开(公告)号:AU2013290185A1
公开(公告)日:2015-01-22
申请号:AU2013290185
申请日:2013-07-11
Applicant: STC UNM
Inventor: SEROV ALEXEY , ATANASSOV PLAMEN B
IPC: B01J37/08 , B01J23/745 , C07D235/30
Abstract: A method of preparation of M-N-C catalytic material utilizing a sacrificial support approach and using inexpensive and readily available metal precursors and carbendazim (CBDZ) as the carbon source is described.
-
公开(公告)号:AU2012323937A1
公开(公告)日:2014-06-05
申请号:AU2012323937
申请日:2012-10-12
Applicant: STC UNM , SANDIA CORP
Inventor: ASHLEY CARLEE ERIN , BRINKER C JEFFREY , CARNES ERIC C , FEKRAZAD MOHAMMAD HOUMAN , FELTON LINDA A , NEGRETE OSCAR , PADILLA DAVID PATRICK , WILKINSON BRIAN S , WILKINSON DAN C , WILLMAN CHERYL L
IPC: A61K9/16 , A61K31/7088 , A61K31/7105 , A61K38/17 , A61K47/48 , A61K48/00 , A61K49/08
Abstract: The present invention is directed to protocells for specific targeting of hepatocellular and other cancer cells which comprise a nanoporous silica core with a supported lipid bilayer; at least one agent which facilitates cancer cell death (such as a traditional small molecule, a macromolecular cargo (e.g. siRNA or a protein toxin such as ricin toxin A-chain or diphtheria toxin A-chain) and/or a histone-packaged plasmid DNA disposed within the nanoporous silica core (preferably supercoiled in order to more efficiently package the DNA into protocells) which is optionally modified with a nuclear localization sequence to assist in localizing protocells within the nucleus of the cancer cell and the ability to express peptides involved in therapy (apoptosis/cell death) of the cancer cell or as a reporter, a targeting peptide which targets cancer cells in tissue to be treated such that binding of the protocell to the targeted cells is specific and enhanced and a fusogenic peptide that promotes endosomal escape of protocells and encapsulated DNA. Protocells according to the present invention may be used to treat cancer, especially including hepatocellular (liver) cancer using novel binding peptides (c-MET peptides) which selectively bind to hepatocellular tissue or to function in diagnosis of cancer, including cancer treatment and drug discovery.
-
公开(公告)号:IL232025D0
公开(公告)日:2014-05-28
申请号:IL23202514
申请日:2014-04-09
Applicant: STC UNM , SANDIA CORP , CARLEE ASHLEY , JEFFIREY BRINKER C , ERIC C CARNES , MOHAMMAD FEKRAZAD , LINDA A FELTON , OSCAR NEGRETE , DAVID PATRICK PADILLA , BRIAN S WILKINSON , DAN C WILKINSON , CHERYL L WILLMAN
IPC: A61K20060101
-
-
-
-
-
-
-
-
-